Coronavirus In India: Corporate Sector Steps Up Fight Against The Deadly Virus

Vedanta has announced to set aside Rs 100 crore initially to support daily wage workers and contract employees working at the mining giant’s factories in India. Sir H. N. Reliance Foundation Hospital in collaboration with the Brihanmumbai Municipal Corporation (BMC) has set up a dedicated 100-bedded centre at Seven Hills Hospital, Mumbai. Industrialist Anand Mahindra will contribute his salary to a coronavirus fund. Pharmaceutical major, Zydus Cadila, is running pre-clinical animal trials for two vaccine candidates, which act completely differently.

Reliance Industries (RIL) on Monday said it has stepped up efforts to help government in its effort to fight against Coronavirus.

RIL has deployed the combined strengths of Reliance Foundation, Reliance Retail, Jio, Reliance Life Sciences, Reliance Industries, and all the 6,00,000 members of the Reliance Family on this action plan against COVID-19, the company said in a statement.

Sir H. N. Reliance Foundation Hospital in collaboration with the Brihanmumbai Municipal Corporation (BMC) has set up a dedicated 100-bedded centre at Seven Hills Hospital, Mumbai, for the patients who test positive for Covid-19.

The facility, fully funded by Reliance Foundation, has built a negative pressure room that helps in preventing cross contamination and helps control infection, it said.

All beds are equipped with the required infrastructure, bio medical equipment such as ventilators, pacemakers, dialysis machine and patient monitoring devices, RIL said.

Reliance Foundation will also provide free meals to people across various cities in partnership with NGOs.

RIL has built a fully-equipped isolation facility in Lodhivali, Maharashtra, and handed it over to the District authorities.

The oil-to-telecom major said Reliance Life Sciences is importing additional test kits and consumables for effective testing.

“Our doctors and researchers are also working overtime to find a cure for this deadly virus.”

“RIL is enhancing its production capacities to produce 100,000 face-masks per day and a large number of personal protective equipment (PPEs) such as suits and garments, for the nation’s health-workers to equip them further to fight the coronavirus challenge.”

Besides that, the company has also announced an initial support of Rs 5 crore to Maharashtra Chief Minister’s Relief Fund.

In association with Microsoft, Jio is facilitating individuals, students, educational and healthcare institutions to continue their professional lives while still practicing social distancing.

Industrialist Anand Mahindra will contribute 100% of his salary over the next few months to a fund created by his automobile-to-hospitality group’s philanthropic arm, which will assist those who have been hit hard in the value chain, such as small businesses and the self-employed. 

Paytm founder Vijay Shekhar Sharma is committing Rs 5 crore to help accelerate development of medical solutions. “We need more Indian innovators to start building indigenous solutions for potential ventilator shortage…Paytm commits Rs 5 crore to teams working on Covid-19 related medical solutions,” Sharma said.

Vedanta said it will not cut salaries or fire any of its employees, including casual workers during this crisis period. 

Pharmaceutical major, Zydus Cadila, is running pre-clinical animal trials for two vaccine candidates, which act completely differently. “In another four to six weeks, we should have the results of the animal trials. One of the vaccines uses recombinant (relating to or denoting an organism, cell, or genetic material formed by recombination) DNA technology and the other uses reverse genetics technology (a line or phrase explaining). Depending on the results of the pre-clinical trials, we will decide which to take forward and apply for approvals from the drugs controller accordingly,” said Pankaj Patel, chairman, Zydus Cadila.

Facebook Comments